All Articles

Browse all articles — filter by topic, how strong the science is, or date.

Showing 97–120 of 416 in Industry & Access

Apr 24, 2026globenewswire.com

Kyowa Kirin and Kura Oncology Initiate Japanese Phase 2 Registration-Directed Trial of Ziftomenib in R/R NPM1-m AML

generalIndustry & Access

Apr 24, 2026globenewswire.com

Tissue Engineering Market to Grow at 12.95% CAGR Reaching USD 27.59 Billion by 2031, Driven by Advances in Regenerative Medicine and Biomaterials, Says Mordor Intelligence

generalIndustry & Access

Apr 24, 2026longevity.technology

4Moving Biotech granted FDA fast track for 4P004

significantIndustry & Access

Apr 24, 2026longevity.technology

Antag Therapeutics to present AT7687 data at ADA 2026

noteworthyIndustry & Access

Apr 23, 2026globenewswire.com

The ROOT Brands Earns National Recognition for Patent‑Driven Wellness Innovation and Science‑Backed Consumer Products

generalIndustry & Access

Apr 23, 2026globenewswire.com

PridCor Therapeutics Secures Global Antiviral Portfolio, Establishing Leadership in Treatment of Long COVID and Infection-Associated Chronic Illnesses

generalIndustry & Access

Apr 23, 2026globenewswire.com

IMAAVY® (nipocalimab)▼shows over two years of sustained disease control in a broad population with generalised myasthenia gravis (gMG)

generalIndustry & Access

Apr 23, 2026globenewswire.com

InnoCare Releases 2026 Q1 Results: Strong Revenue Growth and Sustained Profitability

generalIndustry & Access

Apr 23, 2026globenewswire.com

Dogwood Therapeutics Announces Worldwide Development and Commercialization Partnership for Anti-Viral Assets with Potential Value up to $100M

generalIndustry & Access

Apr 23, 2026globenewswire.com

MBX Biosciences to Host In-Person and Virtual Obesity Day on May 11, 2026 to Discuss Expanding Obesity Portfolio

generalIndustry & Access

Apr 23, 2026globenewswire.com

Reviva to Participate in a Fireside Chat Hosted by A.G.P. on Brilaroxazine’s Potential Across Multiple Neuropsychiatric Indications

generalIndustry & Access

Apr 23, 2026globenewswire.com

ENA Respiratory Appoints Melissa Faris to Board

generalIndustry & Access

Apr 23, 2026globenewswire.com

Santhera Appoints Orlando Oliveira as Chief Executive Officer

generalIndustry & Access

Apr 23, 2026globenewswire.com

Nobelpreisverdächtige Entdeckung von VectorBuilder-Wissenschaftlern deckt grundlegende Entwicklungsmechanismen auf

generalIndustry & Access

Apr 23, 2026globenewswire.com

Santhera ernennt Orlando Oliveira zum Chief Executive Officer

generalIndustry & Access

Apr 22, 2026globenewswire.com

Abivax to Present Data on Obefazimod at Digestive Disease Week®

generalIndustry & Access

Apr 22, 2026longevity.technology

Mesoblast invests in smarter cell therapies with new CAR tech deal

generalIndustry & Access

Apr 22, 2026globenewswire.com

MedShop Direct Expands White Glove Delivery and Installation of Adjustable Medical Beds for Assisted Living and Home Care Across 48 States

generalIndustry & Access

Apr 22, 2026globenewswire.com

HairClub Named Company of the Year for Second Straight Year as Turnaround Drives Growth and Profitability

generalIndustry & Access

Apr 22, 2026globenewswire.com

Adial Pharmaceuticals Successfully Completes Manufacturing of Demonstration Batch Production, Enabling Clinical and Registration Production for AD04 Planned Phase 3 Trial

generalIndustry & Access

Apr 22, 2026globenewswire.com

Amae Health and Novant Health bring enhanced integrated care model for severe mental illness to Charlotte, North Carolina

generalIndustry & Access

Apr 22, 2026globenewswire.com

Femasys Launches FemaSeed® Complete for OB/GYNs at ACOG 2026

generalIndustry & Access

Apr 22, 2026globenewswire.com

Philips receives FDA 510(k) clearance for its Rembra platform, expanding access to faster, more precise CT imaging across frontline care and cancer treatment planning

generalIndustry & Access

Apr 22, 2026globenewswire.com

Cloudbreak Pharma Announces Presentation on its Multi-Kinase Inhibition (MKI) Platform and Ongoing Clinical Programs at Eyecelerator @ ARVO 2026

generalIndustry & Access